Science Corporation has implanted its PRIMA vision-restoring chip in its first Stargardt disease patient, marking a significant milestone in retinal prosthetics. Former Neuralink president Max Hodak highlighted the achievement at TechCrunch Disrupt as part of the company's broader path toward novel brain-computer interface technology.
Background
Stargardt disease is a rare genetic disorder causing progressive vision loss in young people. PRIMA (Photorepair) is a subretinal chip developed by Science Corporation to bypass damaged photoreceptors and restore vision.
- Source
- TechCrunch
- Published
- Oct 14, 2026 at 07:13 AM
- Score
- 6.0 / 10